Theriva Biologics, Inc. Current Liabilities
Theriva Biologics, Inc. (TOVX) had Current Liabilities of $12.11 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Liabilities, Current $12.11M.
- 2026-03-31: Liabilities, Current $10.26M.
- 2025-12-31: Liabilities, Current $10.01M.
- 2025-09-30: Liabilities, Current $11.00M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $12.11M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $10.26M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $10.01M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $11.00M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $12.39M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $8.15M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $7.58M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $7.32M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $6.85M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $6.01M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $6.74M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $8.74M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $9.13M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $8.62M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $7.06M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $12.32M 10-K · filed 2023-03-30 | $13.19M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $12.42M 10-K · filed 2023-03-30 | $13.26M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10.98M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.55M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $3.16M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $2.10M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.12M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $2.97M 10-K · filed 2022-03-16 | |
| 2020-09-30 | $3.01M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $3.43M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.88M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $5.28M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $5.63M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $3.81M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.96M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $3.38M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $3.91M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $4.32M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $5.09M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $9.79M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $17.52M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $12.33M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $16.49M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $19.76M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $14.01M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $15.17M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $17.53M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $15.57M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $17.30M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $25.50M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $15.34M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $9.59M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $984.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $1.23M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $773.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.03M 10-K · filed 2015-03-16 | |
| 2013-06-30 | $229.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $196.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $395.00K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $417.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $395.00K 10-Q/A · filed 2012-09-11 | |
| 2012-03-31 | $443.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $417.00K 10-K · filed 2013-04-16 | |
| 2011-09-30 | $234.03K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $397.88K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $500.00K 10-K/A · filed 2012-05-11 | $500.15K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |